2016•European Urology SupplementsRequires access

1142 Efficacy of atezolizumab (MPDL3280A) in platinum-treated metastatic urothelial carcinoma (mUC): Update from the IMvigor 210 phase II clinical trial

M. van der Heijden, Margitta Retz, José Luis Perez‐Gracia, Andrea Necchi, Thomas Powles, Srikala S. Sridhar, G. Neigisch, Christine Théodore, Sergio Bracarda, Ignacio Durán, Joan Carles, J. Rosenberg, Robert Dreicer, E. Grande, Na Cui, Sanjeev Mariathasan, Ann Christine Thastrom, Yohann Loriot

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Atezolizumab, Medicine, Metastatic Urothelial Carcinoma, Urothelial carcinoma, Urology, Oncology, Internal medicine, Bladder cancer